Pages that link to "Q24300770"
Jump to navigation
Jump to search
The following pages link to Merlin/NF2 loss-driven tumorigenesis linked to CRL4(DCAF1)-mediated inhibition of the hippo pathway kinases Lats1 and 2 in the nucleus (Q24300770):
Displaying 50 items.
- Angiomotin (Q4763281) (← links)
- Neurofibromin 2 (Q14889820) (← links)
- Large tumor suppressor kinase 2 (Q21105103) (← links)
- DDB1 and CUL4 associated factor 1 (Q21112163) (← links)
- Large tumor suppressor kinase 1 (Q21114061) (← links)
- New insights into posttranslational modifications of Hippo pathway in carcinogenesis and therapeutics (Q26752756) (← links)
- Mechanisms of Hippo pathway regulation (Q26771285) (← links)
- YAP and TAZ: a nexus for Hippo signaling and beyond (Q28085636) (← links)
- Distinct and overlapping functions of the cullin E3 ligase scaffolding proteins CUL4A and CUL4B (Q28086765) (← links)
- Recent insights emerging from malignant mesothelioma genome sequencing (Q28388301) (← links)
- The Hippo kinases LATS1 and 2 control human breast cell fate via crosstalk with ERα (Q28596581) (← links)
- Regulation of localization and function of the transcriptional co-activator YAP by angiomotin. (Q30352874) (← links)
- Dual function of partitioning-defective 3 in the regulation of YAP phosphorylation and activation. (Q30357501) (← links)
- Therapeutic advances for the tumors associated with neurofibromatosis type 1, type 2, and schwannomatosis (Q30357776) (← links)
- Merlin status regulates p75(NTR) expression and apoptotic signaling in Schwann cells following nerve injury. (Q30373369) (← links)
- A novel lncRNA uc.134 represses hepatocellular carcinoma progression by inhibiting CUL4A-mediated ubiquitination of LATS1. (Q33576268) (← links)
- Comprehensive pharmacological profiling of neurofibromatosis cell lines (Q33622690) (← links)
- Global Proteome and Phospho-proteome Analysis of Merlin-deficient Meningioma and Schwannoma Identifies PDLIM2 as a Novel Therapeutic Target. (Q33809716) (← links)
- Identification of Happyhour/MAP4K as Alternative Hpo/Mst-like Kinases in the Hippo Kinase Cascade (Q34493871) (← links)
- Neurofibromatosis-related tumors: emerging biology and therapies (Q35218073) (← links)
- Disease implications of the Hippo/YAP pathway (Q35269102) (← links)
- Sox2 antagonizes the Hippo pathway to maintain stemness in cancer cells (Q35601012) (← links)
- MicroRNA-135b regulates apoptosis and chemoresistance in colorectal cancer by targeting large tumor suppressor kinase 2. (Q35757995) (← links)
- Role of Merlin/NF2 inactivation in tumor biology (Q36189820) (← links)
- A novel HMGA1-CCNE2-YAP axis regulates breast cancer aggressiveness (Q36326335) (← links)
- Cullin 4A (CUL4A), a direct target of miR-9 and miR-137, promotes gastric cancer proliferation and invasion by regulating the Hippo signaling pathway (Q36962867) (← links)
- Molecular analysis of aggressive renal cell carcinoma with unclassified histology reveals distinct subsets. (Q37330688) (← links)
- Tead1 regulates the expression of Peripheral Myelin Protein 22 during Schwann cell development (Q37530126) (← links)
- Molecular insights into NF2/Merlin tumor suppressor function (Q38204110) (← links)
- YAP Mediates Tumorigenesis in Neurofibromatosis Type 2 by Promoting Cell Survival and Proliferation through a COX-2-EGFR Signaling Axis (Q38437859) (← links)
- Control of Proliferation and Cancer Growth by the Hippo Signaling Pathway (Q38514410) (← links)
- Cellular Organization and Cytoskeletal Regulation of the Hippo Signaling Network. (Q38857144) (← links)
- Expression and significance of Hippo/YAP signaling in glioma progression (Q39310380) (← links)
- Cell Junctions in Hippo Signaling (Q39363466) (← links)
- Malignant Mesothelioma: Time to Translate? (Q39366003) (← links)
- The LATS1 and LATS2 tumor suppressors: beyond the Hippo pathway (Q39394211) (← links)
- The scaffold protein KSR1, a novel therapeutic target for the treatment of Merlin-deficient tumors (Q40343618) (← links)
- Low Merlin expression and high Survivin labeling index are indicators for poor prognosis in patients with malignant pleural mesothelioma (Q40667179) (← links)
- Rac1-Mediated DNA Damage and Inflammation Promote Nf2 Tumorigenesis but Also Limit Cell-Cycle Progression. (Q41073081) (← links)
- Schwann cell development, maturation and regeneration: a focus on classic and emerging intracellular signaling pathways (Q41429732) (← links)
- NF2 Activates Hippo Signaling and Promotes Ischemia/Reperfusion Injury in the Heart. (Q41492288) (← links)
- Merlin inhibits Wnt/β-catenin signaling by blocking LRP6 phosphorylation (Q41636971) (← links)
- Neurovascular patterning cues and implications for central and peripheral neurological disease (Q41669132) (← links)
- Merlin controls the repair capacity of Schwann cells after injury by regulating Hippo/YAP activity. (Q42323518) (← links)
- Characterization of Hippo Pathway Components by Gene Inactivation (Q45423657) (← links)
- SIRT7 deacetylates DDB1 and suppresses the activity of the CRL4 E3 ligase complexes. (Q45950871) (← links)
- Essential signaling in NF2 loss-related tumours: the therapeutic potential of CRL4DCAF1 and mTOR combined inhibition (Q47138523) (← links)
- Deubiquitylase USP9X suppresses tumorigenesis by stabilizing large tumor suppressor kinase 2 (LATS2) in the Hippo pathway (Q47354887) (← links)
- Regulation of the Hippo Signaling Pathway by Ubiquitin Modification (Q49797883) (← links)
- Tension-dependent regulation of mammalian Hippo signaling through LIMD1. (Q50027256) (← links)